Author: healthadmin

The Texas Environmental Commission on Friday approved an investigation into Tesla’s battery lithium compound manufacturing facility near Robstown in Nueces County, finding that the plant did not violate its wastewater discharge permit. TCEQ began the investigation after workers with the Nueces County Drainage District 2, which manages the ditch area, discovered an unfamiliar pipe extending across the district’s easement and discharging a black liquid into the ditch. Workers filed two complaints with TCEQ on January 20 and February 9 regarding the quality of wastewater discharged from the Tesla facility. On Feb. 12, state investigators evaluated liquid waste from a ditch…

Scientists have identified brain networks that work together when people generate creative scientific ideas, according to a new study published in . Psychology of aesthetics, creativity, and art. Creativity is often associated with art, but scientists rely on it just as much, especially when creating new hypotheses and explanations for puzzling phenomena. Nevertheless, scientific creativity has received far less attention than artistic creativity, or general creative thinking that does not require expertise in a particular field. Previous research has demonstrated that creative thinking generally tends to involve three major brain networks. The first is the default mode network, which helps…

According to PwC, the global women’s health sector could reach $600 billion by 2030, but given underdiagnosis and new digital and consumer-driven models, the opportunity could be even greater. The current global women’s health market is estimated to be between $430 billion and $440 billion, with annual growth rates of 6% to 8% by 2030, according to a new analysis (PDF). Additionally, the core women’s health market, from gynecological conditions to oncology, is currently estimated at $195 billion to $205 billion and is projected to reach $270 billion to $280 billion by 2030. Citing a January 2026 World Economic Forum…

Still basking in the afterglow of launching Wegovy tablets earlier this year, Novo has scored another victory as it strives to make the most of its blockbuster GLP-1 drug in an increasingly pressured obesity market. On Thursday, the FDA approved Novo’s Wegovy HD, a higher-dose 7.2 mg semaglutide injection, for obese adults. The agreement, made through the FDA’s new National Priority Voucher Program, is the fourth approved to date under a regulatory framework designed to dramatically speed up the review of medical products determined to be in U.S. interest. The strength of Novo’s new injectable formulation far exceeds the previous…

Older people with a genetic risk for Alzheimer’s disease did not show the expected cognitive decline or increased risk of dementia, even when they ate relatively large amounts of meat. This is shown in a new study published by Karolinska Institutet. JAMA network open. The results could contribute to the development of more personalized dietary advice. APOE is a gene that influences Alzheimer’s disease risk. In Sweden, approximately 30% of the population are carriers of the APOE 3/4 or APOE 4/4 gene combination. Nearly 70% of people with Alzheimer’s disease have these genotypes. When the Swedish Food Agency published a…

Men’s preconception health startup Upstream has announced PreSeed Fertility, a database for matching sperm donors. We have over 120 registered donors and have been open for several months, representing 10% of our current active donor base in the United States. Rather than storing or distributing sperm, PreSeed partners with licensed clinics, sperm agencies, and legal experts to help match intended parents with suitable donors. Globally, one in six people experience infertility, and nearly half of all cases are due to male factors. When it comes to sperm donation, there is a huge disparity in supply, with far more families looking…

Recent research published in journals molecular psychiatry provide evidence that the genetic risk for major depression tends to be higher in people who develop a more severe form of the condition. By combining genetic data, self-reported symptom questionnaires, and long-term health records, researchers found that people who are genetically more likely to develop depression often report low self-esteem years before they require hospital treatment. “Depression is a common disease in the population, but there is considerable individual variation in the presentation and course of symptoms. Current treatment guidelines are not differentiated enough to address this heterogeneity, and depression remains a…

Professional dance is a high-performance field that carries significant risks of injury and physical wear and tear. Researchers at Goethe University in Frankfurt have for the first time accurately measured strains in the musculoskeletal system. The study involved 28 professional dancers who wore suits with sensors during ballet training. The data revealed high levels of tension during all stages of training. The findings support the development of injury prevention strategies and highlight the high physical demands of this occupation. Ballet is an art of illusion. The dancers appear to be floating across the stage, momentarily seeming to defy gravity as…

Michael Guillot extracts a model painted with Art Nouveau motifs in blue, gray and white from a wooden box of reclaimed floor tiles. “It’s easy to fall in love with it because it has this floral pattern,” said Guyot, a researcher specializing in architectural reuse, holding up a square cement tile that was once common in many homes built in Belgium in the early 20th century. “And in the ’30s and ’40s, more modern patterns started being produced, which is also very interesting.” The crate is just one of dozens of tiles of various styles, sizes and colors waiting to…

A team from the University of Barcelona has designed an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer’s disease and tested it in animal models. Unlike current drugs, which primarily remove beta-amyloid plaques that accumulate in the brain, this new experimental drug reprograms the neuroepigenome by correcting changes in gene expression that contribute to disease progression. The results of this study are molecular therapyopening the door to epigenetics-based therapeutic strategies to combat Alzheimer’s disease. The compound FLAV-27 represents an innovative and promising approach to Alzheimer’s disease, with the potential to modify the disease process as…